Determination of serum adenosine deaminase and xanthine oxidase levels in patients with crimean-congo hemorrhagic fever

Clinics

Volumn 65, Issue 7, 2010, Pages 697-702

  Kenan Celik, V ^a   Sari, Ismail ^a   Engin, Aynur ^a   Yildiz, Gürsel ^a   Aydin, Hüseyin ^a   Bakir, Sevtap ^a  

^a CUMHURIYET UNIVERSITY   (Turkey)

Author keywords

Adenosine deaminase; Crimean Congo hemorrhagic fever; Intracellular enzyme; Nairovirus; Xanthine oxidase

Indexed keywords

ADENOSINE DEAMINASE; BIOLOGICAL MARKER; XANTHINE OXIDASE;

ADULT; ARTICLE; BLOOD; CASE CONTROL STUDY; CHI SQUARE DISTRIBUTION; COLORIMETRY; ENZYMOLOGY; FEMALE; HOSPITALIZATION; HUMAN; IMMUNOLOGY; MALE; MIDDLE AGED; NAIRO VIRUS; PROSPECTIVE STUDY; TURKEY (REPUBLIC);

ADENOSINE DEAMINASE; ADULT; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; CHI-SQUARE DISTRIBUTION; COLORIMETRY; FEMALE; HEMORRHAGIC FEVER VIRUS, CRIMEAN-CONGO; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; TURKEY; XANTHINE OXIDASE; YOUNG ADULT;

EID: 77956767469     PISSN: 18075932     EISSN: None     Source Type: Journal    
DOI: 10.1590/S1807-59322010000700008     Document Type: Article

References (43)

1. Watts DM, Ksiasek TG, Linthicum KJ, Hoogstraal H. Crimean-Congo Hemorrhagic fever. In T.P. Monath, ed. The arboviruses: epidemiology and ecology, vol.2. CRC, Boca Raton, FL,USA. 1988;177-260.
2. Ergönül O, Çelikbaş A, Dokuzoguz B, Eren S, Baykam N, Esener H. The characteristics of Crimean-Congo Hemorrhagic Fever in a recent outbreak in Turkey and the impact of oral ribavirin therapy. Clin Infect Dis. 2004;39:284-7.
3. Ergönül O. Crimean-Congo haemorrhagic fever. Lancet Infect Dis. 2006;6:203-14.
4. Karti SS, Odabaşi Z, Korten V, Yilmaz M, Sönmez M, Caylan R, et al. Crimean-Congo hemorrhagic fever in Turkey. Emerg Infect Dis. 2004;10:1379-84.
5. Bakir M, Ugurlu M, Dokuzoguz B, Bodur H, Tasyaran MA, Vahaboglu H. Crimean-Congo haemorrhagic fever outbreak in Middle Anatolia: a multicentre study of clinical features and outcome measures. J Med Microbiol. 2005;54:385-9.
6. Smego RA, Sarwari AR, Siddiqui AR. Crimean-Congo hemorrhagic fever: Prevention and control limitations in a resource poor country. Clin Infect Dis. 2004;38:1731-5.
7. Mardani M, Jahromi MK, Naieni KH, Zeinali M.The effcacy of oral ribavirin in the treatment of crimean-congo hemorrhagic fever in Iran. Clin Infect Dis. 2003;36:1613-8.
8. Nabeth P, Thior M, Faye O, Simon F. Human Crimean-Congo hemorrhagic fever, Senegal. Emerg Infect Dis. 2004;10:1881-2.
9. Papa A, Bino S, Llagami A, Brahimaj B, Papadimitriou E, Pavlidou V, et al. Crimean Congo hemorrhagic fever in Albania, 2001. Eur J Clin Microbiol Infect Dis. 2002;21:603-6.
10. Papa A, Bozovic B, Pavlidou V, Papadimitriou E, Pelemis M, Antoniadis A. Genetic detection and isolation of Crimean-Congo hemorrhagic fever virus, Kosovo, Yugoslavia. Emerg Infect Dis. 2002;8:852-4.
11. Papa A, Christova I, Papadimitriou E, Antoniadis A. Crimean-Congo hemorrhagic fever in Bulgaria. Emerg Infect Dis. 2004;10:1465-7.
12. Athar MN, Baqai HZ, Ahmad M, Khalid MA, Bashir N, Ahmad AM, et al. Short report: Crimean-Congo hemorrhagic fever outbreak in Rawalpindi, Pakistan. Am J Trop Med Hyg. 2003;69:284-7.
13. Goldfarb LG, Chumakov MP, Myskin AA, Kondratenko VF, Reznikov OY. An epidemiological model of Crimean Hemorrhagic Fever. Am J Trop Med Hyg. 1980; 29:260-4.
14. Elaldi N. Epidemiology of Crimean-Congo hemorrhagic fever, Klimik Derg 2004;17:151-5. Turkish.
15. Swanepoel R, Gill DE, Shepherd AJ, Leman PA,Mynhardt JH, Harvey S. The clinical pathology of Crimean/Congo hemorrhagic fever. Rev Infect Dis. 1989;11:794-800.
16. Schwarz TF, Nsanze H, Ameen AM. Clinical features of Crimean-Congo haemorrhagic fever in the United Arab Emirates. Infection. 1997;25:364-7.
17. Oldfeld EC, Wallace MR, Hyams KC, Yousif AA, Lewis DE, Bourgeois AL. Endemic infectious diseases of the Middle East, Rev Infect Dis. 1991;13:199-217.
18. Celikbas A, Ergonul O, Baykam N, Eren S, Esener H, Dokuzoguz B. Analysis of the mortality among the patients with Crimean Congo Hemorrhagic Fever virus infection. 15th European Congress of Clinical Microbiology and Infectious Diseases, April 2-5, 2005, Copenhagen. Clin Microbiol Infect. 2005;11:19.
19. Burt FJ, Swanepoel R, Shieh WJ, Smith JF, Leman PA, Greer PW, et al. Immunohistochemical and in situ localization of Crimean-Congo hemorrhagic fever (CCHF) virus in human tissues and implications for CCHF pathogenesis. Arch Pathol Lab Med. 1997;121:839-46.
20. Whitehouse CA. Crimean-Congo hemorrhagic fever. Antiviral Res. 2004;64:145-60.
21. Ungerer JP, Oosthuizen HM, Bissbort SH, Vermaak WJ. Serum adenosine deaminase: isoenzymes and diagnostic application. Clin Chem. 1992;38:1322-6.
22. Chittiprol S, Satishchandra P, Bhimasenarao RS, Rangaswamy GR, Sureshbabu SV, Subbakrishna DK, et al. Plasma adenosine deaminase activity among HIV1 Clade C seropositives: relation to CD4 T cell population and antiretroviral therapy. Clin Chim Acta. 2007;377:133-7.
23. Tuon FF, Silva VI, Almeida GM, Antonangelo L, Ho YL. The usefulness of adenosine deaminase in the diagnosis of tuberculous pericarditis. Rev Inst Med Trop. 2007;49: 165-70.
24. Choi SH, Kim YS, Bae IG, Chung JW, Lee MS, Kang JM, et al. The possible role of cerebrospinal fuid adenosine deaminase activity in the diagnosis of tuberculous meningitis in adults. Clin Neurol Neurosurg. 2002;104:10-5.
25. Tripathi K, Kumar R, Bharti K, Kumar P, Shrivastav R, Sundar S, et al. Adenosine deaminase activity in sera of patients with visceral leishmaniasis in India. Clin Chim Acta. 2008;388:135-8.
26. Yokozawa T, Sekiya M, Cho EJ, Kurokawa M, Shiraki K. Effect of Wen-Pi-Tang extract on lung damage by infuenza virus infection. Phytomedicine. 2004;11:625-32.
27. Guisti G, Bernard S. Methods of Enzymatic Analysis. Academic Pres Newyork. 1974; 1092-9.
28. Worthington-Enzyme Manual. Enzymes, Enzyme Reagents, related Biochemicals. Worthington Biochemical Corporation in Freehold, New Jersey, U.S.A. 1972; pp. 216.
29. The reports of Communicable Diseases Department, Ankara, Turkey: Ministry of Health 2007.
30. Midilli K, Gargili A, Ergonul O, Sengöz G, Ozturk R, Bakar M. Imported Crimean-Congo hemorrhagic fever cases in Istanbul. BMC Infect Dis. 2007;7:54.
31. Chan B, Wara D, Bastian J, Hershfeld MS, Bohnsack J, Azen CG, et al. Long-term effcacy of enzyme replacement therapy for adenosine deaminase (ADA)-defcient severe combined immunodefciency (SCID). Clin Immunol. 2005;117:133-43.
32. Nyhan WL. Disorders of purine and pyrimidine metabolism. Mol Genet Metab. 2005; 86:25-33.
33. Moriwaki Y, Yamamoto T, Higashino K. Enzymes involved in purine metabolism-a review of histochemical localization and functional implications. Histol Histopathol. 1999;14:1321-40.
34. Conde MB, Marinho SR, Pereira Mde F, Lapa e Silva JR, Saad MH, Sales CL, et al. The usefulness of serum adenosine deaminase 2 (ADA2) activity in adults for the diagnosis of pulmonary tuberculosis. Respir Med. 2002;96:607-10.
35. Vorbach C, Harrison R, Capecchi MR. Xanthine oxidoreductase is central to the evolution and function of the innate immune system. Trends Immunol. 2003;24:512-7.
36. Cevik MA, Erbay A, Bodur H, Gülderen E, Baştuǧ A, Kubar A, et al. Clinical and laboratory features of Crimean-Congo hemorrhagic fever: predictors of fatality. Int J Infect Dis. 2008;12:374-9.
37. Burt FJ, Paweska JT, Ashkettle B, Swanepoel R. Genetic relationship in southern African Crimean-Congo haemorrhagic fever virus isolates: evidence for occurrence of reassortment. Epidemiol Infect. 2009;137:1302-8.
38. Deyde VM, Khristova ML, Rollin PE, Ksiazek TG, Nichol ST. Crimean-Congo hemorrhagic fever virus genomics and global diversity. J Virol 2006; 80:8834-42.
39. Alataş F, Uslu S, Moral H, Alataş O, Metintaş M, Erginel S, et al. Serum adenosine deaminase activity in pulmonary tuberculosis. Tuberk Toraks. 2003;51:277-81.
40. Fang J, Nakamura H, Iyer AK. Tumor-targeted induction of oxystress for cancer therapy. J Drug Target. 2007;15:475-86.
41. Stirpe F, Ravaioli M, Battelli MG, Musiani S, Grazi GL. Xanthine oxidoreductase activity in human liver disease. Am J Gastroenterol. 2002;97:2079-85.
42. Papa A, Bino S, Velo E, Harxhi A, Kota M, Antoniadis A. Cytokine levels in Crimean-Congo hemorrhagic fever. J Clin Virol. 2006;36:272-6.
43. Ergönül O, Tuncbilek S, Baykam N, Çelikbaş A, Dokuzoguz B. Evaluation of serum levels of interleukin (IL)-6, IL-10, and tumor necrosis factor-alpha in patients with Crimean-Congo hemorrhagic fever. J Infect Dis. 2006;193:941-4.